ClinicalTrials.Veeva

Menu

Melatonin Decreases Eye Pressure in Normotensive Patients

K

Kahramanmaraş Sütçü İmam University (KSU)

Status

Completed

Conditions

Depressive Disorder

Treatments

Drug: Agomelatine 25 MG Oral Tablet

Study type

Observational

Funder types

Other

Identifiers

NCT03193112
KahramanmarasSIU

Details and patient eligibility

About

Agomelatine is a melatonin drug used to treat depressive disorder. Agomelatine may also some effects on ocular pressures. In this study, we aimed to demonstrate that melatonin decreases intraocular pressures when given depressive patients.

Full description

Melatonin has been shown to be effective to decrease intraocular pressure in experimental animal researches. Agomelatine is a melatonin derivative drug approved for the treatment of depression, which is also available in our country. Depending on animal experiments, it can be assumed that agomelatine can decrease intraocular pressure. Demonstrating that agomelatine is effective to reduce eye pressure may give a concurrent treatment of depressive patients with glaucoma. With this it may be possible to treat both diseases at the same time with single drug. In this study, the researchers intended to investigate the changes in ocular tension in normotensive depressive patients treated with agomelatine.

Enrollment

20 patients

Sex

All

Ages

18 to 66 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Depressive patients suitable for Agomelatine therapy for the treatment of their primary disease.

Exclusion criteria

  • Any past history of ocular surgery, ocular trauma or existing ocular diseases

Trial design

20 participants in 1 patient group

Study group
Description:
The investigators analyze the intraocular pressure changes on patients who have been using Agomelatine for their primary depressive disorder. For the treatment of depression, patients will have been started routinely Agomelatine tablet of 25 mg orally. The investigators measure the eye pressure for one months in those patients receiving standard depression treatment.
Treatment:
Drug: Agomelatine 25 MG Oral Tablet

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems